Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Selecta Biosciences Inc (SELB)  
$0.50 0.00 (0.00%) as of 4:30 Thu 4/4


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 108,030,000
Market Cap: 54.46(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4901 - $1.4
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Selecta Biosciences is a clinical-stage biopharmaceutical company. Co.'s ImmTOR® platform encapsulates rapamycin, also known as sirolimus, a Food and Drug Administration approved immunomodulator, in biodegradable nanoparticles ImmTOR is designed to induce antigen-specific immune tolerance. By combining ImmTOR with antigens of interest, Co.'s immune tolerance platform restores self-tolerance to auto-antigens in autoimmune diseases, amplify the ability of biologics (including gene therapies) and mitigate the formation of anti-drug antibodies against biologic drugs.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,222,516 1,223,316 1,223,316 1,403,316
Total Buy Value $688,511 $689,063 $689,063 $877,582
Total People Bought 1 1 1 3
Total Buy Transactions 12 13 13 15
Total Shares Sold 0 0 3,637 15,619
Total Sell Value $0 $0 $3,855 $23,149
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 5
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 258
  Page 7 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Myers Scott Dunseth Director   –       •      –    2019-12-23 4 A $1.46 $57,537 D/D 39,409 80,845     -
   Springer Timothy A Director   –       •       •   2019-12-23 4 A $1.46 $5,753,695 I/I 3,940,887 5,486,463     -
   Cox Carrie Smith Director   –       •      –    2019-12-23 4 A $1.46 $95,894 D/D 65,681 65,681     -
   Barabe Timothy C Director   –       •      –    2019-12-23 4 A $1.46 $95,894 D/D 65,681 83,173     -
   Springer Timothy A Director   –       •       •   2019-12-12 4 A $0.00 $0 D/D 1,237,028 7,293,625     -
   Brunn Carsten President and CEO   •       •      –    2019-12-02 4 S $1.53 $21,809 D/D (14,272) 70,914     -
   Brunn Carsten President and CEO   •       •      –    2019-12-01 4 OE $0.00 $0 D/D 43,750 85,186     -
   Springer Timothy A Director   –       •       •   2019-09-03 4 D $0.00 $0 I/I (1,237,028) 0     -
   Zenner Patrick J Director   –       •      –    2019-08-20 4 A $1.81 $99,999 D/D 55,248 55,248     -
   Kogan Elona Esq. General Counsel   •       –      –    2019-08-20 4 A $1.81 $149,998 D/D 82,872 182,872     -
   Springer Timothy A Director   –       •       •   2019-08-20 4 A $1.81 $1,991,000 I/I 1,100,000 1,545,576     -
   Springer Timothy A Director   –       •       •   2019-08-20 4 A $1.81 $2,896,000 D/D 1,600,000 6,056,597     -
   Brunn Carsten President and CEO   •       •      –    2019-08-20 4 A $1.81 $74,999 D/D 41,436 41,436     -
   Kishimoto Takashi Kei Chief Scientific Officer   •       –      –    2019-08-20 4 A $1.81 $90,500 D/D 50,000 86,114     -
   Smolinski Stephen Chief Commercial Officer   •       –      –    2019-08-20 4 A $1.81 $25,000 D/D 13,812 13,812     -
   Myers Scott Dunseth Director   –       •      –    2019-08-20 4 A $1.81 $74,999 D/D 41,436 41,436     -
   Springer Timothy A Director   –       •       •   2019-08-14 4 B $1.74 $17,415 I/I 10,000 86,418 2.17     -
   Barabe Timothy C Director   –       •      –    2019-08-13 4 B $1.72 $17,200 D/D 10,000 17,492 2.39     -
   Johnston Lloyd P. COO and SVP, R&D   •       –      –    2019-07-23 4 OE $0.47 $4,700 D/D 10,000 11,606     -
   Kogan Elona Esq. General Counsel   •       –      –    2019-03-25 4 A $0.00 $0 D/D 100,000 100,000     -
   Springer Timothy A Director   –       •      –    2019-01-25 4 B $1.50 $99,999 I/I 66,666 76,418 2.1     -
   Springer Timothy A Director   –       •      –    2019-01-25 4 B $1.50 $6,000,000 D/D 4,000,000 4,456,597 2.39     -
   Farokhzad Omid Director   –       •      –    2019-01-25 4 B $1.50 $125,000 I/I 83,333 83,333 2.1     -
   Nashat Amir Director   –       •      –    2019-01-25 4 B $1.50 $1,749,999 I/I 1,166,666 2,676,234 2.1     -
   Kishimoto Takashi Kei Chief Scientific Officer   •       –      –    2019-01-07 4 OE $2.77 $100,036 D/D 36,114 36,114     -
  258 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us